Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CHAMPIONS ONCOLOGY, INC.CSBR · Entity 7013 | Director · CEO | March 17, 2023 | March 21, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CHAMPIONS ONCOLOGY, INC.
Report date March 17, 2023 · Filed March 21, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 858,878 |
Reported balance
After 2023-03-17 transaction · row 1
1 source rowRow 1 · 2023-03-17 · Purchase · Acquired 12,382 · Balance 858,878 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 21, 2016 Filed Sep 21, 2016 18:24 UTC Amendment | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | Disposition to issuerOption to purchase Common Stock · Derivative | 182,580 | Not disclosed Strike: $4.92 | Not disclosed |
DisclosureSEC source: 0001628280-16-019672 · wf-form4a_147448223854668.xml · derivative · entry 9 Morris Ronnie · CIK 0001504443 · Director · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 182,580 shares Expires 2025-10-20 F2 · price: The reporting person agreed to the cancellation of options granted to him on March 16, 2015 and November 19, 2015 in exchange for new options having a lower exercise price. F4 · derivative.exercise_date: Vesting to occur upon completion of performance criteria that have not been set. Read SEC document |
| July 21, 2016 Filed Sep 21, 2016 18:24 UTC Amendment | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | Disposition to issuerOption to purchase Common Stock · Derivative | 182,580 | Not disclosed Strike: $4.92 | Not disclosed |
DisclosureSEC source: 0001628280-16-019672 · wf-form4a_147448223854668.xml · derivative · entry 8 Morris Ronnie · CIK 0001504443 · Director · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 182,580 shares Expires 2020-10-25 F2 · price: The reporting person agreed to the cancellation of options granted to him on March 16, 2015 and November 19, 2015 in exchange for new options having a lower exercise price. F6 · derivative.exercise_date: Fully Vested. Read SEC document |
| July 21, 2016 Filed Sep 21, 2016 18:24 UTC Amendment | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | GrantOption to purchase Common Stock · Derivative | 88,595 | Not disclosed Strike: $2.10 | Not disclosed |
DisclosureSEC source: 0001628280-16-019672 · wf-form4a_147448223854668.xml · derivative · entry 7 Morris Ronnie · CIK 0001504443 · Director · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,595 Underlying: Common Stock · 88,595 shares Expires 2025-11-01 F2 · price: The reporting person agreed to the cancellation of options granted to him on March 16, 2015 and November 19, 2015 in exchange for new options having a lower exercise price. F5 · derivative.exercise_date: Vested as to 66,446 shares on grant; remainder to vest on October 31, 2016. Read SEC document |
| July 21, 2016 Filed Sep 21, 2016 18:24 UTC Amendment | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | GrantOption to purchase Common Stock · Derivative | 83,026 | Not disclosed Strike: $2.10 | Not disclosed |
DisclosureSEC source: 0001628280-16-019672 · wf-form4a_147448223854668.xml · derivative · entry 6 Morris Ronnie · CIK 0001504443 · Director · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,026 Underlying: Common Stock · 83,026 shares Expires 2025-11-01 F2 · price: The reporting person agreed to the cancellation of options granted to him on March 16, 2015 and November 19, 2015 in exchange for new options having a lower exercise price. F1 · derivative.exercise_date: Fully vested upon grant. Read SEC document |
| July 21, 2016 Filed Sep 21, 2016 18:24 UTC Amendment | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | GrantOption to purchase Common Stock · Derivative | 14,552 | Not disclosed Strike: $2.10 | Not disclosed |
DisclosureSEC source: 0001628280-16-019672 · wf-form4a_147448223854668.xml · derivative · entry 5 Morris Ronnie · CIK 0001504443 · Director · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,552 Underlying: Common Stock · 14,552 shares Expires 2023-11-05 F2 · price: The reporting person agreed to the cancellation of options granted to him on March 16, 2015 and November 19, 2015 in exchange for new options having a lower exercise price. F1 · derivative.exercise_date: Fully vested upon grant. Read SEC document |
| July 21, 2016 Filed Sep 21, 2016 18:24 UTC Amendment | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | GrantOption to purchase Common Stock · Derivative | 101,521 | Not disclosed Strike: $2.10 | Not disclosed |
DisclosureSEC source: 0001628280-16-019672 · wf-form4a_147448223854668.xml · derivative · entry 4 Morris Ronnie · CIK 0001504443 · Director · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 101,521 Underlying: Common Stock · 101,521 shares Expires 2023-11-05 F2 · price: The reporting person agreed to the cancellation of options granted to him on March 16, 2015 and November 19, 2015 in exchange for new options having a lower exercise price. F4 · derivative.exercise_date: Vesting to occur upon completion of performance criteria that have not been set. Read SEC document |
| July 21, 2016 Filed Sep 21, 2016 18:24 UTC Amendment | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | GrantOption to purchase Common Stock · Derivative | 101,521 | Not disclosed Strike: $2.10 | Not disclosed |
DisclosureSEC source: 0001628280-16-019672 · wf-form4a_147448223854668.xml · derivative · entry 3 Morris Ronnie · CIK 0001504443 · Director · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 101,521 Underlying: Common Stock · 101,521 shares Expires 2023-11-05 F2 · price: The reporting person agreed to the cancellation of options granted to him on March 16, 2015 and November 19, 2015 in exchange for new options having a lower exercise price. F3 · derivative.exercise_date: Vested as to 74,529 shares on grant; remainder to vest on November 5, 2016. Read SEC document |
| July 21, 2016 Filed Sep 21, 2016 18:24 UTC Amendment | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | GrantOption to purchase Common Stock · Derivative | 150,795 | Not disclosed Strike: $2.10 | Not disclosed |
DisclosureSEC source: 0001628280-16-019672 · wf-form4a_147448223854668.xml · derivative · entry 2 Morris Ronnie · CIK 0001504443 · Director · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,795 Underlying: Common Stock · 150,795 shares Expires 2020-10-25 F2 · price: The reporting person agreed to the cancellation of options granted to him on March 16, 2015 and November 19, 2015 in exchange for new options having a lower exercise price. F1 · derivative.exercise_date: Fully vested upon grant. Read SEC document |
| July 21, 2016 Filed Sep 21, 2016 18:24 UTC Amendment | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | GrantOption to purchase Common Stock · Derivative | 150,795 | Not disclosed Strike: $2.10 | Not disclosed |
DisclosureSEC source: 0001628280-16-019672 · wf-form4a_147448223854668.xml · derivative · entry 1 Morris Ronnie · CIK 0001504443 · Director · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,795 Underlying: Common Stock · 150,795 shares Expires 2020-10-25 F2 · price: The reporting person agreed to the cancellation of options granted to him on March 16, 2015 and November 19, 2015 in exchange for new options having a lower exercise price. F1 · derivative.exercise_date: Fully vested upon grant. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.